Overexpression and downregulation of SGLT1 were further used to demonstrate the connection at a genetic level between the JNK and p38 pathway and SGLT1 inhibition in DCM (Figures 9E–H). This evidence concerns the gene SLC5A1 and familial dilated cardiomyopathy.